March 14, 2025
The Myrio team recently participated in the Spring edition of the Society for Immunotherapy of Cancer (SITC), where Matt Beasley (Co-founder, CSO) and Dr. Lauren Pitt (Head of Preclinical) presented at […]
November 12, 2024
Psaio Therapeutics (subsidery of Myrio Therapeutics) is thrilled to announce that it has been selected as a finalist in the 2024 ANZ Advance Biotech Grant Program […]